Cargando…

Which future for aspirin in acute coronary syndromes treated with percutaneous coronary intervention? An overview on aspirin-free strategies

Detalles Bibliográficos
Autores principales: Spadafora, Luigi, Bernardi, Marco, Galli, Mattia, Biondi-Zoccai, Giuseppe, Sabouret, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710287/
https://www.ncbi.nlm.nih.gov/pubmed/36457983
http://dx.doi.org/10.5114/aoms/155411
_version_ 1784841333258584064
author Spadafora, Luigi
Bernardi, Marco
Galli, Mattia
Biondi-Zoccai, Giuseppe
Sabouret, Pierre
author_facet Spadafora, Luigi
Bernardi, Marco
Galli, Mattia
Biondi-Zoccai, Giuseppe
Sabouret, Pierre
author_sort Spadafora, Luigi
collection PubMed
description
format Online
Article
Text
id pubmed-9710287
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-97102872022-11-30 Which future for aspirin in acute coronary syndromes treated with percutaneous coronary intervention? An overview on aspirin-free strategies Spadafora, Luigi Bernardi, Marco Galli, Mattia Biondi-Zoccai, Giuseppe Sabouret, Pierre Arch Med Sci Letter to the Editor Termedia Publishing House 2022-11-07 /pmc/articles/PMC9710287/ /pubmed/36457983 http://dx.doi.org/10.5114/aoms/155411 Text en Copyright: © 2022 Termedia & Banach https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Letter to the Editor
Spadafora, Luigi
Bernardi, Marco
Galli, Mattia
Biondi-Zoccai, Giuseppe
Sabouret, Pierre
Which future for aspirin in acute coronary syndromes treated with percutaneous coronary intervention? An overview on aspirin-free strategies
title Which future for aspirin in acute coronary syndromes treated with percutaneous coronary intervention? An overview on aspirin-free strategies
title_full Which future for aspirin in acute coronary syndromes treated with percutaneous coronary intervention? An overview on aspirin-free strategies
title_fullStr Which future for aspirin in acute coronary syndromes treated with percutaneous coronary intervention? An overview on aspirin-free strategies
title_full_unstemmed Which future for aspirin in acute coronary syndromes treated with percutaneous coronary intervention? An overview on aspirin-free strategies
title_short Which future for aspirin in acute coronary syndromes treated with percutaneous coronary intervention? An overview on aspirin-free strategies
title_sort which future for aspirin in acute coronary syndromes treated with percutaneous coronary intervention? an overview on aspirin-free strategies
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710287/
https://www.ncbi.nlm.nih.gov/pubmed/36457983
http://dx.doi.org/10.5114/aoms/155411
work_keys_str_mv AT spadaforaluigi whichfutureforaspirininacutecoronarysyndromestreatedwithpercutaneouscoronaryinterventionanoverviewonaspirinfreestrategies
AT bernardimarco whichfutureforaspirininacutecoronarysyndromestreatedwithpercutaneouscoronaryinterventionanoverviewonaspirinfreestrategies
AT gallimattia whichfutureforaspirininacutecoronarysyndromestreatedwithpercutaneouscoronaryinterventionanoverviewonaspirinfreestrategies
AT biondizoccaigiuseppe whichfutureforaspirininacutecoronarysyndromestreatedwithpercutaneouscoronaryinterventionanoverviewonaspirinfreestrategies
AT sabouretpierre whichfutureforaspirininacutecoronarysyndromestreatedwithpercutaneouscoronaryinterventionanoverviewonaspirinfreestrategies